Table 1 Reported cases of hepatic MALT lymphoma
From: Primary hepatic mucosa-associated lymphoid tissue lymphoma: a case report and literature review
Case | Sex/age | HBV | HCV | Concomitant disease | Tumor no. | Treatment | Outcome |
|---|---|---|---|---|---|---|---|
1 | M/66 | ND | ND | Ureteral cancer | 1 | Resection | 12 M/alive |
2 | F/73 | ND | ND | (−) | 1 | Resection | Lost to follow-up |
3 | M/85 | ND | ND | Prostatic cancer | 2 | (−) | Death after other surgery |
4 | F/60 | ND | ND | Liver cirrhosis | Multiple | Transplantation | 12 M/dead |
5 | F/57 | (−) | ND | Ascariasis | 1 | Resection | 55 M/alive |
6 | M/48 | (+) | ND | Hepatitis | 1 | Resection + Chemotherapy | 38 M/alive |
7 | F/47 | (−) | (−) | Multiple biliary unilocular cysts | 1 | Resection + Radiation | 30 M/alive |
8 | M/64 | (−) | (−) | Colon cancer | 1 | Resection | Lost to follow-up |
9 | F/62 | (−) | (−) | Primary biliary cirrhosis | 1 | Resection | 6 M/alive |
10 | F/64 | (−) | (+) | Liver cirrhosis | 1 | Chemotherapy | 24 M/alive |
11 | F/65 | (−) | (+) | Hepatitis | 1 | Chemotherapy | 48 M/alive |
12 | F/69 | (−) | (−) | (−) | 1 | Resection | Short time/alive |
13 | F/41 | (−) | (−) | Primary biliary cirrhosis | 1 | (−) | 12 M/alive |
14 | F/64 | (−) | (−) | (−) | 1 | Resection | 72 M/alive |
15 | F/57 | (−) | (−) | Primary biliary cirrhosis | 1 | Transplantation | 9 M/alive |
16 | F/64 | (−) | (−) | Ascariasis | 1 | Resection | Pulmonary recurrence after 96 M |
17 | F/59 | ND | ND | ND | Multiple | Resection + Chemotherapy | ND |
18 | M/61 | (−) | (−) | Gastric cancer | 1 | Resection | 18 M/alive |
19 | M/73 | (−) | (+) | Liver cirrhosis | 1 | Resection | 34 M/alive |
20 | M/59 | (−) | (+) | Hepatitis | 1 | Resection | 30 M/alive |
21 | F/50 | (−) | (−) | (−) | 1 | Resection + Chemotherapy | 30 M/alive |
22 | F/72 | ND | ND | Colon cancer | 1 | (−) | 1 M/dead |
23 | F/61 | ND | ND | Rheumatoid arthritis | 1 | (−) | Dead |
24 | F/58 | ND | ND | (−) | Multiple | Resection + Chemotherapy | 37 M/alive |
25 | F/62 | ND | ND | Breast cancer | 1 | Resection | 9 M/alive |
26 | F/65 | (+) | (−) | Hepatocellular carcinoma | 1 | Resection | 10 M/alive |
27 | F/60 | (−) | (−) | Gastric MALT lymphoma | 1 | (−) | 30 M/alive |
28 | M/59 | (+) | (−) | Liver cirrhosis | 2 | Transplantation | 6 M/Alive |
29 | M/36 | (+) | (−) | Hepatitis | 1 | Resection | Hepatic recurrence after 40 M |
30 | M/53 | (−) | (+) | Liver cirrhosis | Multiple | Transplantation + Chemo | ND |
31 | M/67 | (−) | (−) | Hepatitis (drug) | 1 | Radiation | Pulmonary recurrence after 72 M |
32 | M/69 | (−) | (−) | (−) | 2 | RFA + Chemo | 24 M/alive |
33 | F/74 | (−) | (−) | (−) | 1 | Resection + Chemotherapy | 6 M/alive |
34 | F/67 | NA | NA | Gastric MALT lymphoma | Multiple | (−) | 1 M/dead |
35 | F/72 | (−) | (−) | Colon cancer | 1 | Resection | 24 M/alive |
36 | M/64 | (−) | (−) | Gastric cancer | Multiple | (−) | 24 M/alive |
37 | M/71 | (−) | (−) | (−) | 1 | Resection | 15 M/alive |
38 | M/71 | (−) | (−) | (−) | 1 | Resection + Chemotherapy | 45 M/alive |
39 | F/56 | (−) | (−) | (−) | 1 | Resection | Pulmonary recurrence after 84 M |
40 | M/59 | (−) | (−) | (−) | 1 | Resection | 5 M/alive |
41 | M/86 | (+) | (−) | Hepatitis | 1 | (−) | 15 M/alive |
42 | M/58 | (−) | (+) | Hepatitis | 1 | Resection + Chemotherapy | 6 M/alive |
43 | F/43 | (−) | (−) | Gastric cancer | 1 | Resection | 24 M/alive |
44 | F/80 | (−) | (−) | Primary biliary cirrhosis | Multiple | Chemotherapy | ND |
45 | M/76 | (−) | (+) | Hepatitis | 1 | Radiation | 60 M/alive |
46 | F/74 | (−) | (−) | Colon cancer | 2 | Resection | 24 M/alive |
47 | F/74 | (−) | (−) | Primary biliary cirrhosis | Multiple | Chemotherapy | 36 M/alive, no relapse |
48 | M/73 | (−) | (+) | Hepatitis | Multiple | Chemotherapy | 24 M/alive, relapse |
49 | F/56 | (−) | (−) | (−) | 1 | Resection | 13 M/alive |
50 | M/77 | (−) | (+) | Hepatitis | 1 | Resection | 8 M/alive |
Our case | M/74 | (−) | (−) | (−) | 1 | Resection | 30 M/alive |